EUR 0.87
(-3.89%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 1.06 Million EUR | -149.09% |
2022 | 5.62 Million EUR | -40.36% |
2021 | 9.42 Million EUR | -11.61% |
2020 | 10.66 Million EUR | 41.69% |
2019 | 7.52 Million EUR | 16.5% |
2018 | 6.46 Million EUR | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | -828 Thousand EUR | -247.33% |
2024 Q2 | -1.07 Million EUR | -29.35% |
2024 Q3 | 1.05 Million EUR | 198.51% |
2023 FY | -2.76 Million EUR | -149.09% |
2023 Q4 | 562 Thousand EUR | 0.0% |
2023 Q1 | 1.76 Million EUR | 13.07% |
2023 Q3 | 562 Thousand EUR | -63.22% |
2023 Q2 | 1.52 Million EUR | -13.18% |
2022 Q3 | 1.55 Million EUR | 173.55% |
2022 Q4 | 1.55 Million EUR | 0.0% |
2022 FY | 5.62 Million EUR | -40.36% |
2022 Q2 | 569 Thousand EUR | -54.64% |
2022 Q1 | 1.25 Million EUR | -38.28% |
2021 Q4 | 2.03 Million EUR | 13.2% |
2021 FY | 9.42 Million EUR | -11.61% |
2021 Q3 | 1.79 Million EUR | -26.53% |
2021 Q2 | 2.44 Million EUR | 2.62% |
2021 Q1 | 2.38 Million EUR | -45.85% |
2020 Q3 | 1.99 Million EUR | 0.0% |
2020 FY | 10.66 Million EUR | 41.69% |
2020 Q4 | 4.39 Million EUR | 120.89% |
2019 FY | 7.52 Million EUR | 16.5% |
2018 FY | 6.46 Million EUR | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
BBS-Bioactive Bone Substitutes Oyj | -3619.00 EUR | 29472.755% |
Nexstim Plc | 2.31 Million EUR | 54.021% |
Revenio Group Oyj | 45.27 Million EUR | 97.652% |